Source: Health Products Regulatory Authority (ZA) Revision Year: 2021 Publisher: GlaxoSmithKline South Africa (Pty) Ltd, 39 Hawkins Avenue, Epping Industria 1, 7460
GENEMIST 27,5 μg/spray, nasal spray suspension.
Pharmaceutical Form |
---|
Nasal spray, suspension. A white uniform suspension. |
Each 50 μl spray contains 27,5 μg of fluticasone furoate.
Preservatives: benzalkonium chloride 0,015% m/m and disodium edetate 0,015% m/m.
Excipient with known effect:
Benzalkonium chloride.
For the full list of excipients, see section 6.1.
Active Ingredient |
---|
Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action. |
List of Excipients |
---|
Glucose anhydrous |
The nasal spray container consists of an inner container within an outer device. The inner container consists of a Type I or Type III amber glass bottle, closed with a metering spray pump. The outer device is a predominantly off-white side-actuated plastic delivery system with a light blue lever and lid containing a stopper. The outer plastic cover has a window for viewing the bottle contents.
GENEMIST is available in three pack sizes:
Not all pack sizes may be marketed.
GlaxoSmithKline South Africa (Pty) Ltd, 39 Hawkins Avenue, Epping Industria 1, 7460
41/21.5.1/0967
12 June 2009
Drug | Countries | |
---|---|---|
GENEMIST | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.